Iorio, Raffaele

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology

Myasthenia Gravis and ThymomaPeripheral Neuropathies and Disorders

Cited by 295

Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis

Damato, V., Evoli, A., & Iorio, R. (2016) · JAMA Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 290

Changes in Demographic and Clinical Characteristics of MuSK Myasthenia Gravis

Falso, S., Marini, S., Marini, M., Habetswallner, F., Evoli, A., & Iorio, R. (2026) · European Journal of Neurology

Myasthenia Gravis and ThymomaInflammatory Myopathies and Dermatomyositis

Cited by 0